Navigation Links
FDA Approves Seasonal Influenza Vaccine Fluarix for Pediatric Use
Date:10/19/2009

SILVER SPRING, Md., Oct. 19 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved use of the seasonal influenza vaccine Fluarix for children ages 3 years to 17 years. Previously, this vaccine, which contains inactivated (killed) influenza A and B viruses, had been approved for use in adults, ages 18 years and older.

(Logo: http://www.newscom.com/cgi-bin/prnh/20090824/FDALOGO)

The safety and effectiveness of Fluarix for use in children ages 3 years and older is documented by a U.S. study comparing 2,115 children who received Fluarix with 1,210 children who received Fluzone, a different influenza vaccine already licensed by the FDA for use in children ages 6 months and older. Study results showed that children 3 years and older vaccinated with Fluarix and Fluzone produced similar amounts of antibodies in the blood at levels considered likely to be protective against seasonal influenza.

Fluarix is a seasonal influenza vaccine not intended to protect against the 2009 H1N1 influenza virus.

"This approval of an additional seasonal influenza vaccine for children provides help in protecting them against influenza," said Karen Midthun, M.D., acting director of the FDA's Center for Biologics Evaluation and Research. "Children are very vulnerable to the influenza virus and are more likely to be hospitalized for associated problems."

With today's approval, there are now four companies approved by the FDA to manufacture seasonal influenza vaccine for use in children.

Influenza is far more dangerous than the common cold for children, who often require medical care, especially if they are younger than 5 years. It is best to vaccinate children each fall, but vaccination also can occur in the winter months when influenza season often peaks.

Common adverse events experienced after administration
'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. FDA Approves New Treatment for Advanced Form of Kidney Cancer
2. FDA Approves Elitek(R) (rasburicase) for Management of Plasma Uric Acid Levels in Adults with Leukemia, Lymphoma, and Solid Tumors Receiving Anti-Cancer Therapy
3. FDA Approves Cervarix, GlaxoSmithKlines Cervical Cancer Vaccine
4. U.S. Food and Drug Administration Approves CRESTOR(R) for Use in Pediatric Patients With Heterozygous Familial Hypercholesterolemia
5. Chinese Food and Drug Administration Approves Gabexate Mesylate as Pharmaceutical Raw Material
6. FDA Approves New Indication For Mirena(R) to Treat Heavy Menstrual Bleeding in IUD Users
7. US FDA Approves Extavia(R) - the First in a New Portfolio of Planned MS Therapies from Novartis to Help Patients with this Devastating Disease
8. Video: FDA Approves INVEGA(R) SUSTENNA(TM) for the Acute and Maintenance Treatment of Schizophrenia
9. FDA Approves Tekturna HCT(R) as Initial Treatment in Patients Unlikely to Achieve Their Blood Pressure Goals With a Single Agent
10. FDA Approves ADCIRCA(TM) (Tadalafil) Tablets for the Treatment of Pulmonary Arterial Hypertension
11. FDA Approves Vanda Pharmaceuticals Fanapt(TM) for the Treatment of Schizophrenia
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... 2015  Today we bring you a special edition of #MedicareMonday on Medicare,s 50 ... some of our Medicare resources and continue highlighting the success of the prescription drug ... Check out our latest infographics and videos here: http://onphr.ma/1INp9qQ ... ... ...
(Date:7/30/2015)... July 30, 2015  Amgen (NASDAQ: AMGN ) today ... managing director of Warburg Pincus LLC, to the Amgen Board ... Fred Hassan and the deep, global experience he ... Robert A. Bradway , chairman and chief executive officer ... will serve Amgen well." Mr. Hassan has been ...
(Date:7/30/2015)... July 30, 2015 Future Market ... titled, "Continuous Glucose Monitoring Systems Market: Global Industry Analysis ... report, the global continuous glucose monitoring systems market was ... expected to reach US$ 788.4 Mn by 2020, registering ... to 2020. Global continuous glucose monitoring systems ...
Breaking Medicine Technology:Happy 50th Anniversary Medicare! 2Happy 50th Anniversary Medicare! 3Amgen Announces Appointment Of Fred Hassan To Board Of Directors 2Amgen Announces Appointment Of Fred Hassan To Board Of Directors 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 2Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 3Global Continuous Glucose Monitoring (CGM) Systems Market: Transmitters and Monitors Most Dominant Segment, Says Future Market Insights 4
... announces that a new market research report is ... Triple Analysis: Leukemia, Prostate Cancer and Apoptosis ... This triple analysis focuses on cancer drug development ... by the mechanism/target/effect of Apoptosis. Each of these ...
... SILVER SPRING, Md., May 3, 2011 The U.S. ... Commission (FTC) today announced a joint effort to remove ... treat, cure, and prevent sexually transmitted diseases (STDs). Among ... Viruxo, C-Cure, and Never An Outbreak. (Logo: ...
Cached Medicine Technology:Reportlinker Adds Triple Analysis: Leukemia, Prostate Cancer and Apoptosis 2Reportlinker Adds Triple Analysis: Leukemia, Prostate Cancer and Apoptosis 3Reportlinker Adds Triple Analysis: Leukemia, Prostate Cancer and Apoptosis 4FDA, FTC Act To Remove Fraudulent STD Products From The Market 2FDA, FTC Act To Remove Fraudulent STD Products From The Market 3
(Date:7/30/2015)... ... July 30, 2015 , ... The connection between a healthy head of hair and a feeling ... a full head of hair can have a devastating impact on the daily life of ... the work place, the consequences of hair loss are not to be taken lightly. , ...
(Date:7/30/2015)... ... July 30, 2015 , ... In a meaningful ritual intended to symbolize a ... Treatment Center have created an addiction graveyard. Sharing this with the public comes at ... Rocky Hudson . Hudson (1945-2015) fell in love with the desert when he ...
(Date:7/30/2015)... ... , ... The American Telemedicine Association (ATA) is seeking presentations ... on telemedicine, telehealth and mHealth. The meeting, expected to attract over 6,000 attendees ... 14-17, 2016 in Minneapolis, MN. , ATA’s annual meeting attracts the world’s most ...
(Date:7/30/2015)... ... 2015 , ... " DevExpress ” was featured on NewsWatch ... medium, and large businesses making an impact in their industry. Susan Bridges, a ... with viewers how DevExpress has provided software development tools that have helped app ...
(Date:7/30/2015)... (PRWEB) , ... July 30, ... ... released a video, “Beachside Nursing Center,” to announce its position as one ... ratings. Beachside's administrator and staff members support the CMS rating system, which ...
Breaking Medicine News(10 mins):Health News:New Study Shows the Link between Hair Restoration and Healthy Self-Image 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 2Health News:Presentation Proposals for ATA 2016 are Now Being Accepted Online at ATA2016.com 3Health News:Software to Develop High-Performance Data-Driven Apps was Featured on NewsWatch Television 2Health News:Beachside Nursing Center Releases New Video 2
... begun to help,United Healthcare Workers-West members fight unprecedented ... International Union President and,Secretary-Treasurer., "A Salute to ... Health Care Workers-West and their President, Sal Rosselli, ... at the Julia Morgan,Ballroom, Merchants Exchange Building, 465 ...
... Lasers Limited (ASX:,ELX), a global leader in the ... today announced the six-month clinical study results,for the ... annual meeting of the American Academy of Ophthalmology.,The ... FRCPath,FRCOphth (Hons), of St. Thomas, Hospital, London, under ...
... E, C did little to protect healthy men, either ... studies released Sunday cast doubt on the cardiac benefits ... Japanese researchers found that low-dose aspirin did not reduce ... 2 diabetes. , Second, Harvard researchers concluded that neither ...
... to foil a tumor from generating blood vessels to feed ... creating drugs aimed at stopping a key vessel growth-promoting protein. ... Researchers at the Moores Cancer Center at the University of ... that blocking that protein target, called VEGF, or vascular endothelial ...
... Room #283-285, Ernest N. Morial Convention Center) , A team ... five key proteins out of thousands secreted into blood draining ... certain quantities form the basis of a far more accurate ... attack in people with severely reduced blood flow, or ischemia. ...
... less likely than Caucasian patients to undergo coronary ... successful angioplasty, a type of percutaneous coronary intervention ... Hispanics also had a trend toward lower ... and bypass surgery, according to a study presented ...
Cached Medicine News:Health News:Health Care Workers Get Help Fighting Unprecedented Attacks from Service Employee International Union Leadership 2Health News:Ellex Announces Six-Month Results on Retina Regeneration Therapy 2Health News:Ellex Announces Six-Month Results on Retina Regeneration Therapy 3Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 2Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 3Health News:Aspirin Doesn't Guard Diabetics Against Heart Disease 4Health News:Cancer drugs my build and not tear down blood vessels 2Health News:Cancer drugs my build and not tear down blood vessels 3Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 2Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 3Health News:Quintet of proteins forms new, early-warning blood test before heart attack strikes 4Health News:Hispanics less likely to have repeat revascularizations 1 year after angioplasty 2
... Immunoassay Control is a ... designed to complement the ... Immunoassay Plus Controls. This ... to include more complex ...
Liquichek Hematology-8 Control is a whole blood hematology control with extended stability for non-differential analyzers....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Liquichek Autoimmune Controls are individual controls for monitoring the performance of autoimmune assays....
Medicine Products: